Mariner, LLC Erytech Pharma S.A. Transaction History

Mariner, LLC

  • $55.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.34 - $1.38 $10,393 - $42,183
-30,568 Reduced 56.12%
23,904 $23,000
Q4 2022

Feb 14, 2023
SELL
$0.33 - $0.68 $1,650 - $3,400
-5,000 Reduced 8.41%
54,472 $18,000
Q3 2022

Nov 10, 2022
BUY
$0.6 - $1.31 $35,683 - $77,908
59,472 New
59,472 $33,000

About Erytech Pharma S.A.

ERYP Quotes by TradingView
  • Ticker ERYP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,018,600
  • Market Cap $16.8M
  • Description
  • ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. Its lead product candidate is eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of...
More about ERYP
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email